Shanghai HeartCare Medical Technology Corp Ltd
06609
Company Profile
Business description
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
Contact
No. 356, Zhengbo Road
Floor 1 and 3, Building 38
Pilot Free Trade Zone
Lingang New District
Shanghai
CHNT: +86 2137526556
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
425
Stocks News & Analysis
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,951.00 | 31.90 | 0.36% |
| CAC 40 | 8,171.48 | 32.54 | 0.40% |
| DAX 40 | 25,694.01 | 119.00 | 0.47% |
| Dow JONES (US) | 52,163.97 | 115.14 | 0.22% |
| FTSE 100 | 10,746.24 | 7.23 | 0.07% |
| HKSE | 25,087.75 | 45.04 | 0.18% |
| NASDAQ | 27,227.41 | 105.32 | 0.39% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,875.48 | 54.28 | 0.39% |
| S&P 500 | 7,779.50 | 14.80 | 0.19% |
| S&P/ASX 200 | 8,757.80 | 25.90 | 0.30% |
| SSE Composite Index | 3,952.13 | 2.22 | 0.06% |